Global progressive policing

Pharma crime: The illicit market of counterfeit drugs

Policing Insight’s Andrew Staniforth looks at the continuing growth in pharmaceutical crime, highlighted by a recent Europol report which suggests that the proliferation in fake and sub-standard medicines prompted by Covid-19 has continued and expanded since the end of the pandemic, with co-operation and intelligence sharing among police and the private sector one of the key steps to tackling the crime.

To read this article you need to have an individual paid subscription or subscriber access via your organisation’s corporate subscription.

Please sign in to your account or subscribe to a plan below to read this article.

If your organisation has a corporate subscription please register a FREE account with your organisation email address for full subscriber access.


Having problems creating an account or can't sign in? Please e-mail [email protected]

Request a password reset using the form below


Having problems creating an account or can't sign in? Please e-mail [email protected]



Having problems creating an account or can't sign in? Please e-mail [email protected]

Top